GenEdit Inc

GenEdit Inc

GenEdit Inc

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Founded
2016
Raised
$34.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$26,000,000
Venture capital (Series A) - 2021
Sequoia Capital IMM Investment Korea Investment Partners +7
$8,500,000
Seed fund - 2018
Team Size
1–10
Employees
$26,000,000 Venture capital (Series A)
MedCity News

Aiming for better genetic medicines delivery, startup GenEdit grabs $26M

$8,500,000 Seed fund
StartupWorld , FinSMEs , PE HUB

GenEdit Closes $8.5 Million Series Seed Financing